Clinical Trial: Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
Sponsor and Collaborators
University of Arkansas
Contact
Contact: Mark Mosby, BS, CCRP
501-526-6990 ext 2440
[email protected]
Contact: Priscilla Newman
501-526-6990 ext 2445
[email protected]
Principal Investigator
Frits Van Rhee, M.D., Ph.D.
ClinicalTrials.gov Identifier
NCT00090493
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting Oncology Nurse Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Please login or register first to view this content.